Conduct of the study The study is coordinated, monitored, and steered by the Sponsors clinical operations and data management staff, under the direction of the Sponsors Chief Medical Officer
Tirzepatide may cause slightly more nausea than semaglutide, especially at higher doses
Weight loss drugs are big business: globally, the market for anti-obesity medications is projected to reach $50 billion by 2030
Semaglutides effects extend to decreasing the risk of heart failure, heart attacks, and other major cardiovascular problems by also reducing the inflammation that can damage blood vessels
Doctors have noted that patients recieve notable improvements in weight management and blood glucose levels, which has led to heightened interest in its potential benefits
Some studies in men and women show that melatonin can reduce anxiety before surgery